SÃO PAULO, August 9, 2026, 19:17 (BRT)
- Ambev’s ADR finished Friday at $3.00, while its shares traded in São Paulo closed at R$15.48. Cash markets in both Brazil and the United States were shut on Sunday.
- Normalized profit for the second quarter exceeded the pre-release consensus by 16.2%, but revenue fell short by 2.6%.
- Minutes from Brazil’s Copom and July inflation data are due on Tuesday. U.S. July CPI will be released Wednesday.
Shares of Ambev S.A. (NYSE:ABEV; BVMF:ABEV3) ADRs declined 3.5% over the past week, ending Friday at $3.00. Adjusted profit for the second quarter surpassed estimates by 16.2%, while volume, revenue and EBITDA came in below expectations.
The division is a concern for investors. Profit surpassed expectations by R$485.7 million versus Ambev’s pre-release consensus.
In numerical terms, this came close to the R$487.9 million year-on-year reduction in net finance expense. Ambev did not provide a consensus figure for finance, so the comparison is not causal.
| Second-quarter metric | Actual | Pre-release consensus estimate | Surprise |
|---|---|---|---|
| Volume, ’000 hectoliters | 39,727.9 | 40,500 | -1.9% |
| Net revenue, R$ million | 20,148.9 | 20,697 | -2.6% |
| Normalized EBITDA, R$ million | 6,376.7 | 6,416 | -0.6% |
| Normalized profit, R$ million | 3,492.7 | 3,007 | +16.2% |
Estimates before the release were gathered from 13 sell-side companies. Surprise percentages are based on figures reported by Ambev.
The operating result remained robust. Organic revenue climbed 6.1%, normalized EBITDA grew 8.9%, and the margin expanded by 80 basis points to reach 31.6%.
Chief Executive Carlos Lisboa stated that execution led to “another quarter of beer volume growth.” He additionally pointed to “solid top and bottom-line performance.”
Brazil beer led the quarter, with organic volume up 5.0%, revenue increasing by 8.9%, and normalized EBITDA climbing 12.8%. Non-alcoholic volume in Brazil declined 4.4%.
Cash conversion improved. Operating cash flow increased by 54.5% to R$4.71 billion. The board authorized approximately R$1.1 billion in interest on capital (IOC).
| Security or index | August 7 close | Weekly change |
|---|---|---|
| Ambev ADR NYSE:ABEV | $3.00 | -3.5% |
| Ambev common shares BVMF:ABEV3 | R$15.48 | -3.2% |
| Anheuser-Busch InBev SA/NV NYSE:BUD | $83.76 | -3.1% |
| Heineken N.V. AMS:HEIA | €77.14 | -1.8% |
| Ibovespa | 172,513 | -3.1% |
| S&P 500 | 7,757.64 | +3.6% |
Stock and Ibovespa shifts are based on July 31 and August 7 closing prices. The S&P result reflects its stated weekly performance.
The weekly performance was not solely driven by company-specific factors. Ambev’s movement was closely aligned with both its domestic shares, Anheuser-Busch InBev, and the Ibovespa index. Heineken outperformed.
The gap remains significant. Ambev lagged behind the S&P 500 by 7.1 percentage points, even though it posted higher margins and improved cash flow.
Sell-side sentiment stays cautious. FactSet NYSE:FDS reports a Hold consensus from 19 active ratings.
| FactSet rating | Three months prior | Now |
|---|---|---|
| Buy | 3 | 3 |
| Overweight | 2 | 1 |
| Hold | 10 | 10 |
| Underweight | 1 | 1 |
| Sell | 4 | 4 |
| Consensus | Hold | Hold |
Analysts’ average price target stands at $3.23, spanning from $2.60 to $4.00.
The number of Overweight ratings is down to one, compared to two three months prior. FactSet’s consensus price target suggests a 7.7% potential gain from Friday’s closing level.
Ambev has not scheduled any company events for this week. The brewer’s next earnings announcement is set for October 29.
The minutes from Tuesday’s Copom meeting come after last week’s reduction of the Selic rate to 14%. On the same day, Brazil’s July IPCA is due, while the U.S. CPI is expected Wednesday.
Such releases have the potential to impact the real and local discount rates. As a result, adjustments to estimates following results become the more immediate catalyst specific to the company.
Risks: Brazil beer cash COGS per hectoliter is projected to rise by 4.5% to 7.5% this year, excluding sales through third-party marketplaces. A filing also highlights potential losses from a R$32.8 billion IOC-related uncertain tax treatment, for which no provision has been made.
For a sustained rerating, investors might be looking for an operating outperformance. This quarter produced a clearer surprise beneath EBITDA.
Related articles: NYSE:ABEV
